Nobutaka Hanagata - Nanotechnology

Author Information

Nobutaka Hanagata is affiliated with the Nanotechnology Innovation Station at the National Institute for Materials Science, located at 1-2-1 Sengen, Tsukuba, Ibaraki, 305-0047, Japan. His research primarily focuses on various aspects of nanotechnology and its applications in biomedical fields.

Research Contributions

Nobutaka Hanagata has made significant contributions to the field of nanotechnology, with a particular focus on its application in biomedical sciences. His recent works include developing water-soluble silicon quantum dots for fluorescence-guided photothermal nanotherapy and visualizing procollagen Iα1 to understand intracellular processing of propeptides. He has also investigated imiquimod microneedles for treating warts, and identified mechanomics biomarkers for cancer cells that are unidentifiable through morphology and elastic modulus. His research extends to the synthesis and modification of nanomaterials for various biomedical applications, including cancer therapy, immunotherapy, and neuron protection.

Aliases

Nobutaka Hanagata is also known by the following aliases: N Hanagata, N. Hanagata, and Nobutaka Hanagata.

Publication and Citation Metrics

Metric	Value
Citation Count	8082
h-index	47
Paper Count	210

Publications:

Water-Soluble Silicon Quantum Dots toward Fluorescence-Guided Photothermal Nanotherapy.

DOI: 10.1021/acs.langmuir.1c02326

Year: 2022

Visualized procollagen Iα1 demonstrates the intracellular processing of propeptides

DOI: 10.26508/lsa.202101060

Year: 2022

A Perspective on Imiquimod Microneedles for Treating Warts

DOI: 10.3390/pharmaceutics13050607

Year: 2021

Mechanomics Biomarker for Cancer Cells Unidentifiable through Morphology and Elastic Modulus.

DOI: 10.1021/acs.nanolett.1c00003

Year: 2021

Intrinsically Substitutional Carbon Doping in CVD-Grown Monolayer MoS2 and the Band Structure Modulation

DOI: 10.1021/acsaelm.0c00076

Year: 2020

Monomeric G-Quadruplex-Based CpG Oligodeoxynucleotides as Potent Toll-Like Receptor 9 Agonists.

DOI: 10.1021/acs.biomac.0c00679

Year: 2020

Praja1 RING‐finger E3 ubiquitin ligase suppresses neuronal cytoplasmic TDP‐43 aggregate formation

DOI: 10.1111/neup.12694

Year: 2020

Effect of immunosuppressants on a mouse model of osteogenesis imperfecta type V harboring a heterozygous Ifitm5 c.-14C > T mutation

DOI: 10.1038/s41598-020-78403-1

Year: 2020

Nano-Bio Interaction between Blood Plasma Proteins and Water-Soluble Silicon Quantum Dots with Enabled Cellular Uptake and Minimal Cytotoxicity

DOI: 10.3390/nano10112250

Year: 2020

PDZK1-interacting protein 1 (PDZK1IP1) traps Smad4 protein and suppresses transforming growth factor-β (TGF-β) signaling

DOI: 10.1074/jbc.RA118.004153

Year: 2019

What is the Future of Stain Resistant Fabrics in Nanotechnology?

Can Nanotechnology Help in Water Desalination?

What are Nanotechnology Coatings?

What are Nanocoatings?

What Are Some Applications of Nanotechnology in Cooling?

What Challenges are Faced in AI-Driven Nanotechnology?

What Are the Applications of Nanotechnology in Wireless Sensor Networks?

What are High Contrast Ratios?

How Can We Ensure Ethical Considerations?

Why are Epitaxial Layers Important in Nanotechnology?

Partnered Content Networks

Relevant Topics